Lexaria Bioscience Corp. Income Statement
LEXX|10 years of annual SEC 10-K data (FY2015-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
Lexaria Bioscience Corp. reported $464,278 in revenue and $6M in net loss for FY2025. Revenue has grown at a 46.8% compound annual rate over the past 9 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $464.3K | $226.2K | $255.4K | $722.7K | $314.8K | $222.6K | $433.3K | $40.7K | $14.7K | $0 |
| Cost of Revenue | $4.8K | $31.5K | $71.8K | $175.3K | $99.4K | $22.9K | $25.2K | $45.6K | $29.9K | $0 |
| Gross Profit | $459.5K | $194.7K | $183.6K | $547.4K | $215.4K | $199.7K | $408.1K | -$4.9K | -$15.2K | $0 |
| SG&A Expense | $3.9M | $3.1M | $5.0M | $5.0M | $4.0M | $297.2K | $217.7K | $97.1K | $18.8K | $11.6K |
| R&D Expense | $2.4M | $3.7M | $1.8M | $1.3M | $387.1K | $555.7K | $492.9K | $9.0K | $146.5K | $0 |
| Operating Income | -$5.8M | -$6.5M | -$6.6M | -$5.7M | - | - | - | - | -$2.0M | -$1.6M |
| Interest Expense | - | $43.2K | - | - | - | - | - | $2.3K | $31.5K | $165.8K |
| Income Tax | - | - | - | $6.1K | $2.3K | $17.7K | $0 | - | - | - |
| Net Income | -$5.8M | -$6.7M | -$7.3M | -$4.0M | -$4.1M | -$4.2M | -$6.6M | - | - | -$1.6M |
| EPS (Diluted) | -$0.47 | -$1.01 | - | - | -$1.47 | -$0.05 | -$0.09 | -$0.03 | -$0.04 | -$0.14 |
| Shares Outstanding | 15.8M | 8.1M | 6.0M | 5.7M | 3.0M | 78.8M | 75.5M | 51.3M | 43.8M | 34.2M |
| Gross Margin | 99.0% | 86.1% | 71.9% | 75.7% | 68.4% | 89.7% | 94.2% | -12.0% | -103.3% | - |
| Operating Margin | -1239.2% | -2888.5% | -2591.7% | -786.9% | - | - | - | - | -13489.8% | - |
| Profit Margin | -1248.3% | -2946.4% | -2846.3% | -557.2% | -1297.6% | -1868.0% | -1525.4% | - | - | - |